Market bias continues to remain on upside: Sandeep Wagle, Power My Wealth

"Whatever corrections we have seen and whatever shifting we have seen, the bias still continues to remain on the upside."

Market bias continues to remain on upside: Sandeep Wagle, Power My Wealth
In a chat with ET Now, Sandeep Wagle, Founder & CEO, Power My Wealth, shares his market outlook. Excerpts:

ET Now: On a closing basis, a 20-point cut for the Nifty is nothing. If I look at the character of the market action, it is clearly disturbing. At higher levels, there is supply; at lower levels, there is demand. What is going on?

Sandeep Wagle: A painful consolidation is what I would describe the Nifty as or maybe even the Bank Nifty move. I do not think 7450 will be broken. I do not think 7680-7700 on the upside will also be broken. So, we will move within that 7500-7700 band. 150, 180, 200-point band with more of stock-specific moves. Whatever corrections we have seen and whatever shifting we have seen, the bias still continues to remain on the upside. So I would be positive, but yes, you have to choose the right sector and right stock.

ET Now: Is it important now to focus on both sides of the market, which is a long side and the short side, because for the longest time those who have traded long, they made money, those who traded short, they have only lost money?

Sandeep Wagle: It is very important to be with the larger trend, which is on the upside. So I would not be comfortable with the idea of going short. Yes, on a day where there is a correction, one can take a punt as intraday trade. That is a different issue, but there is no question of carrying forward your shorts. It is better to be long. Even if you are wrong, you will get a chance to exit at profit. So in that sense there is no question of going short.

ET Now: So what are your top ideas for tomorrow?
ADVERTISEMENT

Sandeep Wagle: PVR is a 'buy' call which gave a very clear breakout with a stop loss of Rs 660 and a target of Rs 735. The second call is a buy in pharma stock, Pfizer, with a stop loss of Rs 1330 and a target of Rs 1435.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Opinion › Interviews › Market bias continues to remain on upside: Sandeep Wagle, Power My Wealth
Text Size:AAA
Success
This article has been saved

*

+